High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis
Authors:
- Christian MortensenCMChristian Mortensen
- Ove AndersenOAOve Andersen
- Aleksander KragAKAleksander Krag
- Flemming BendtsenFBFlemming Bendtsen
- Søren MøllerSMSøren Møller
- 1 June 2012
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 24 (6) , 619-626
Abstract
Inflammation may be implicated in the haemodynamic deterioration and in the development of complications in patients with cirrhosis. High-sensitivity C-reactive protein (hsCRP) is a marker of low-grade inflammation, and predicts outcomes in patients at risk of ischaemic heart disease. Proinflammatory cytokines reflect immune activation and have been found to be elevated in cirrhosis. We investigated a possible association between markers of inflammation and splanchnic and systemic haemodynamics, complications and survival in patients with cirrhosis. In 45 stable patients with cirrhosis on the basis of alcohol consumption, we measured hsCRP, as well as monocyte chemoattractant protein-1, tumour necrosis factor-α, interleukin-6, interleukin-8 and vascular endothelial growth factor in patients and in 12 healthy controls. Systemic and splanchnic haemodynamics were investigated in patients. hsCRP levels were significantly higher in patients compared with controls (P<0.05) and the highest in patients belonging to Child-Pugh class C. hsCRP levels correlated with markers of liver dysfunction and with the hepatic venous pressure gradient (r=0.48, P<0.001). hsCRP values above the median level of 5.3 mg/l were associated with a highly increased mortality (P=0.001). Model for End-Stage Liver Disease score (P=0.01) and hsCRP (P<0.05) provided independent prognostic information. Cytokines had no discernible value in predicting survival. hsCRP is elevated in patients with cirrhosis and is associated with portal hypertension and decreased survival. hsCRP is a promising prognostic marker in cirrhosis, which may improve the selection of candidates for liver transplantation.Keywords
This publication has 29 references indexed in Scilit:
- Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining PrognosisGastroenterology, 2010
- Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated CirrhosisGastroenterology, 2007
- Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndromeJournal of Gastroenterology and Hepatology, 2005
- Circulatory function and hepatorenal syndrome in cirrhosis†Hepatology, 2005
- Gut microflora in the pathogenesis of the complications of cirrhosisBest Practice & Research Clinical Gastroenterology, 2004
- Prevention of Gram-Negative Translocation Reduces the Severity of Hepatopulmonary SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Bacterial infection in the pathogenesis of variceal bleedingThe Lancet, 1999
- Interleukin-6: an early marker of bacterial infection in decompensated cirrhosisJournal of Hepatology, 1994
- Tumor necrosis factor α and interleukin 6 plasma levels in infected cirrhotic patientsGastroenterology, 1993
- Serum levels of cytokines in chronic liver diseasesGastroenterology, 1992